Insight Molecular Diagnostics Inc. Common Stock vs. Intellia Therapeutics, Inc
IMDX
Insight Molecular Diagnostics Inc. Common Stock
$3.44 -0.86%
VS NTLAIntellia Therapeutics, Inc
$12.36 +0.82%
Insight Molecular Diagnostics Inc. Common Stock and Intellia Therapeutics, Inc are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| IMDX | NTLA | |
|---|---|---|
| Market Cap | $113.55 million | $1.72 billion |
NTLA leads on 1 of 1 size & scale factors.
Risk & Sentiment
| IMDX | NTLA | |
|---|---|---|
| Short Interest | 0.93% | 2.43% |
IMDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: IMDX overview, IMDX financials, NTLA overview, NTLA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.